Top

Published in:

01-12-2012 | Original Paper

Over-expression of tumor necrosis factor-α in vitiligo lesions after narrow-band UVB therapy: an immunohistochemical study

Authors: Enayat Attwa, Hend Gamil, Magda Assaf, Sohair Ghonemy

Published in: Archives of Dermatological Research | Issue 10/2012

Abstract

There is a growing evidence that cytokines are important in the depigmentation process of vitiligo, however, the exact mechanism is not fully understood. The aim of this work was to study the possible role of the tumor necrosis factor-α (TNF-α) cytokine in the depigmentation process of the disease. Twenty patients with generalized vitiligo were exposed to narrow-band ultraviolet B (NB-UVB) therapy thrice weekly for a total of 60 sessions. Immunohistochemical examination was done, to assess the TNF-α expression in lesional and perilesional skin as compared to normal control skin, before and after therapy. At baseline, positive lesional TNF-α expression was detected in 60 % of patients which was significantly higher as compared to perilesional skin (20 %) and negative expression in healthy control skin. Post-treatment, a statistically significant increase in TNF-α expression was detected in both lesional (90 %) and perilesional skin (70 %) as compared to baseline (P < 0.05). The significant increase of TNF-α in vitiligo lesions compared with perilesional and healthy skin suggests a possible involvement of this cytokine in the depigmentation of vitiligo. The increase in TNF-α expression after NB-UVB phototherapy suggests another role in repigmentation.

Arca E, Tastan HB, Erbil AH et al (2006) Narrow band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. J Dermatol 33:338–343PubMedCrossRef

Birol A, Kisa U, Kurtipek GS et al (2006) Increased tumour necrosis factor alpha (TNF-α) and interleukin 1 alpha (IL-1α) levels in the lesional skin of patients with nonsegmental vitiligo. Int J Dermatol 45:992–993PubMedCrossRef

Brazzelli V, Antoninetti M, Palazzini S et al (2007) Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with NB-UVB phototherapy. J Eur Acad Dermatol Venereol 21:1369–1374PubMedCrossRef

Brink N, Szamel M, Young AR et al (2000) Comparative quantification of IL-1β, IL-10, TNF-α and IL-7 mRNA levels in UV irradiated skin in vivo. Inflamm Res 49:290–296PubMedCrossRef

Cui J, Shen LY, Wang GC (1991) Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 97:410–416PubMedCrossRef

Eves PC, Bullett NA, Haddow D et al (2008) Simplifying the delivery of melanocytes and keratinocytes for the treatment of vitiligo using a chemically defined carrier dressing. J Invest Dermatol 128(6):1554–1564PubMedCrossRef

Fitzpatrick TB (1997) Mechanisms of phototherapy in vitiligo. Arch Dermatol 133:1591–1592PubMedCrossRef

Goktas EO, Aydin F, Senturk N et al (2006) Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo. J Eur Acad Dermatol Venereol 20:553–557PubMedCrossRef

Grimes PE, Morris R, Avaniss-Aghajani T et al (2004) Topical tacrolimus therapy for vitiligo. Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 51(1):52–61PubMedCrossRef

10.

Hamzavi I, Jain H, McLean D et al (2004) Parametric modeling of narrow band UV-B phototherapy for vitiligo using a novel quantitative tool. Arch Dermatol 140:677–683PubMedCrossRef

11.

Hino R, Kobayashi T, Mori H et al (2007) Inhibition of T helper 2 chemokine production by narrow-band ultraviolet B in cultured keratinocytes. Br J Dermatol 156:830–837PubMedCrossRef

12.

Joshi PG, Nair N, Begum G et al (2007) Melanocyte-keratinocyte interaction induces calcium signalling and melanin transfer to keratinocytes. Pigment Cell Res 20(5):380–384PubMed

13.

Kang HY, Kang WH (2004) Leukomelanoderma following acute cutaneous graft-versus-host disease. Eur J Dermatol 14(3):146–149PubMed

14.

Kawaguchi M, Mitsuhashi Y, Kondo S (2005) Over expression of tumor necrosis factor α-converting enzyme in psoriasis. Br J Dermatol 152(5):915–919PubMedCrossRef

15.

Köck A, Shwarz T, Kirnbauer R et al (1990) Human keratinocytes are a source for tumour necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609–1614PubMedCrossRef

16.

Leverkus M, Yaar M, Eller MS et al (1998) Post transcriptional regulation of UV induced TNF-alpha expression. J Invest Dermatol 110:353–357PubMedCrossRef

17.

Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275PubMed

18.

Martinez-Esparzo M, Jimenez-Cervantes C, Solano F et al (1998) Mechanisms of melanogenesis inhibition by tumour necrosis factor-α in melanoma cells. Eur J Biochem 255:139–146CrossRef

19.

Moretti S, Spallanzani A, Amato L et al (2002) New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 15:87–92PubMedCrossRef

20.

Njoo MD, Bos JD, Westerhof W (2000) Treatment of generalized vitiligo in children with narrow band (TL-01) UVB radiation therapy. J Am Acad Dermatol 42:245–253PubMedCrossRef

21.

Scherschun L, Kim JJ, Lim HW (2001) Narrow band ultraviolet-B is a useful and well tolerated treatment for vitiligo. J Am Acad Dermatol 44(6):999–1003PubMedCrossRef

22.

Schwarz A, Maeda A, Wild MK et al (2004) Ultraviolet radiation induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol 172:1036–1043PubMed

23.

Schwarz T (2002) Photoimmunosuppression. Photodermatol Photoimmunol Photomed 18:141–145PubMedCrossRef

24.

Seité S, Colige A, Deroanne C et al (2004) Changes in matrix gene and protein expressions after single or repeated exposure to one minimal erythemal dose of solar-stimulated radiation in human skin in vivo. Photochem Photobiol 79:265–271PubMedCrossRef

25.

Shang J, Eberle J, Geilen CC et al (2002) The role of nuclear factor-kappa B and melanogenesis in tumor necrosis factor-alpha-induce. Skin Pharmacol Appl Skin Physiol 15:321–329PubMedCrossRef

26.

Shintani Y, Yasuda Y, Kobayashi K et al (2008) Narrow band UVB radiation suppresses contact hypersensitivity. Photodermatol Photoimmunol Photomed 24:32–37PubMedCrossRef

27.

Skov L, Hansen H, Allen M et al (1998) Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor alpha in human skin. Br J Dermatol 138:216–220PubMedCrossRef

28.

Wallace ML, Smoller BR (1996) Immunohistochemistry in diagnostic dermatopathology. J Am Acad Dermatol 34(2):163–183PubMedCrossRef

29.

Westerhof W, d’ Ischia M (2007) Vitiligo puzzle, the pieces fall in place. Pigment Cell Res 20(5):345–359PubMed

Title: Over-expression of tumor necrosis factor-α in vitiligo lesions after narrow-band UVB therapy: an immunohistochemical study
Authors: Enayat Attwa
Hend Gamil
Magda Assaf
Sohair Ghonemy
Publication date: 01-12-2012
Publisher: Springer-Verlag
Published in: Archives of Dermatological Research / Issue 10/2012
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-012-1269-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Over-expression of tumor necrosis factor-α in vitiligo lesions after narrow-band UVB therapy: an immunohistochemical study

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2012

PGP 9.5 distribution patterns in biopsies from early lesions of atopic dermatitis

Role of translocator protein in melanoma growth and progression

Abrogating effect of a xanthophyll carotenoid astaxanthin on the stem cell factor-induced stimulation of human epidermal pigmentation

T-regulatory cells in severe atopic dermatitis: alterations related to cytokines and other lymphocyte subpopulations

Interactions between FLG mutations and allergens in atopic dermatitis

Subtoxic levels hydrogen peroxide-induced expression of interleukin-6 by epidermal melanocytes